Investors / Flu Lab
Flu Lab
Investor
Flu Lab is a philanthropic organization that funds and invests in efforts to eliminate the threat of influenza. It provides grants, makes investments in early-stage companies, and collaborates with partners to accelerate new solutions for global influenza challenges.
Invests inHealthcare & Biotech
In its own wordsinfluenzapublic healthinfectious diseasevaccinesdiagnosticstherapeutics
Your fit with Flu Lab
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsFlu Lab lists 20 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series B, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (88%) and Education (12%). 67% of its companies are based in United States. It invests most often alongside Almaworks, Bay City Capital and Brandon BioCatalyst.
Counts come from funding rounds that name Flu Lab, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Flu Lab's whole history. Rounds on record name 1 company; its own site lists 20. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 100% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 51th | 20 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 63th | 5% of companies confirmed by a round |
| Sector focus | 95th | 88% in its largest sector |
| Reach | 70th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Almaworks | 1 |
| Bay City Capital | 1 |
| Brandon BioCatalyst | 1 |
| Brandon Capital | 1 |
| Deeptech Labs | 1 |
| Eight Capital | 1 |
| Genki Ventures | 1 |
| Holland Capital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers20100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 88% | 15% |
| Education | 12% | 7% |
Co-investor network
who it backs companies with, and who they back togetherCompare Flu Lab head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Flu Lab| Date | Company | Stage |
|---|---|---|
| 22 Oct 2025 | Series B |
Round details for Flu Lab
Amounts, full round histories and every co-investor in Flu Lab's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
20 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| The company builds nasal sprays that combine world-class science and innovative formulations to enhance everyday health. | Healthcare & Biotech | Portfolio page | ||
| Blueprint Biosecurity is a nonprofit advancing practical, pathogen-agnostic countermeasures to reduce the impact of future biological threats. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Portfolio page | ||||
| Emory University is an academic institution that offers various programs and conducts research in multiple fields, including health care. | EducationHealthcare & Biotech | Portfolio page | ||
| ENA Respiratory is a clinical-stage pharmaceutical company developing antiviral host defense enhancers for the prevention of severe complications from respiratory viral infections in vulnerable populations. | Healthcare & Biotech | Oct 2025Series B | Page + round | |
| Global Health Investment Corporation catalyzes the development of technologies to improve human health worldwide | Healthcare & Biotech | Portfolio page | ||
| Intercept is a philanthropic initiative that aims to reduce the burden of respiratory infections | Healthcare & Biotech | Portfolio page | ||
| The International Society for Respiratory Viruses is an independent and international scientific professional society promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases. | Healthcare & Biotech | Portfolio page | ||
| PHF Science is a New Zealand Government-owned research organisation dedicated to the health, wellbeing and safety of our communities | Healthcare & Biotech | Portfolio page | ||
| Pictura Bio is developing a suite of technologies to scale diagnostics at the point of care. | Healthcare & Biotech | Portfolio page | ||
| Protas enables clinical trials to become a solution to some of the world's biggest health problems through smart trial design and delivery, effective use of data and technology, and collaborative policy development. | Healthcare & Biotech | Portfolio page | ||
| The company provides education through various undergraduate and postgraduate study areas, as well as short courses and professional education. | Education | Portfolio page | ||
| Scout develops portable molecular testing technology for fast and accurate medical testing | Healthcare & Biotech | Portfolio page | ||
| St. Jude Children's Research Hospital treats and researches childhood cancer and other life-threatening diseases. | Healthcare & Biotech | Portfolio page | ||
| Taza Aya develops wearable air curtain devices for respiratory protection | Healthcare & Biotech | Portfolio page | ||
| The company conducts research in microbiology. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Vivaldi Biosciences is developing vaccines for protection against epidemic and pandemic viral respiratory diseases. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- theflulab.org
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 22 Oct 2025
- Companies checked
- 20
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Flu Lab's profile as data
Pull Flu Lab's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/theflulab.org
# also
GET /v1/firms/theflulab.org/portfolio
GET /v1/firms/theflulab.org/coinvestors
GET /v1/firms/theflulab.org/news